Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Qforma, which traffics in analytics and predictive modeling, hired Erin McLaughlin as director of field operations. She last worked as an account manager at Surveillance Data Inc (SDI) and before that was with NDCHealth (which is now Wolters Kluwer Health), where she was in sales and management.

Migenix appointed Paul Brennan as chief executive officer;
Watson Pharma names R. Todd Joyce to chief financial officer;
Quintiles hired Bob Rhoades to head the Quality Systems business units;
Quintiles tapped Mike Swiatocha as head of R&D compliance;
Quintiles BIMO Consulting hired Jan Holladay Pierce as a principal consultant;
Time-Warner adds Schering-Plough’s Fred Hassan to its board;
Santaris Pharma hired Mark Wedel as vp and chief medical officer;
Santaris Pharma added Stuart Mackey as vp strategy and chief business officer;
Cephalon hired Bob Repella as senior vp of pharmaceutical operations;
MWW Group hired Paul Aronsohn, former Pfizer public affairs executive, as a vp;
Epizyme named Hoyoung Huh as board chairman;
Aileron Therapeutics appointed Steve Kafka as chief financial officer;
Wyeth India appointed Kewal Handa as managing director;
Inovio Biomedical elected David Williams and Keith Wells to its board.
National Pharmaceutical Council elected Pfizer’s Marie-Caroline Sainpy as chairman;